Cargando…
The resurrection of RIP kinase 1 as an early cell death checkpoint regulator—a potential target for therapy in the necroptosis era
Receptor-interacting serine threonine protein kinase 1 (RIPK1) has emerged as a central molecular switch in controlling the balance between cell survival and cell death. The pro-survival role of RIPK1 in maintaining cell survival is achieved via its ability to induce NF-κB-dependent expression of an...
Autores principales: | Ju, Eunjin, Park, Kyeong Ah, Shen, Han-Ming, Hur, Gang Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534832/ https://www.ncbi.nlm.nih.gov/pubmed/36171264 http://dx.doi.org/10.1038/s12276-022-00847-4 |
Ejemplares similares
-
Life after death: RIP1 and RIP3 move beyond necroptosis
por: Berger, SB, et al.
Publicado: (2016) -
HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis
por: Park, Han-Hee, et al.
Publicado: (2018) -
RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)
por: Liu, Yuping, et al.
Publicado: (2019) -
The RIP1–RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats
por: Cui, Hongwang, et al.
Publicado: (2016) -
Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
por: Cruz, Shelly A., et al.
Publicado: (2018)